Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Katie C. Russell"'
Autor:
Sean D. Madsen, Katie C. Russell, H. Alan Tucker, Julie Glowacki, Bruce A. Bunnell, Kim C. O’Connor
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-14 (2017)
Abstract Background Mesenchymal stem cells (MSCs) are a mixture of progenitors that are heterogeneous in their regenerative potential. Development of MSC therapies with consistent efficacy is hindered by the absence of an immunophenotype of MSC heter
Externí odkaz:
https://doaj.org/article/26223c1776b1403197475bf7c564df10
Autor:
H. Alan Tucker, Carson T. Discher, Sean D. Madsen, Katie C. Russell, Mimi C. Sammarco, Margaret K. Giler, Sean H. Jones, Dyllan C. Muller, Bruce A. Bunnell, Kim C. O'Connor, Georgina L Dobek
Publikováno v:
Biotechnology and Bioengineering. 117:223-237
In vivo mesenchymal stem cell (MSC) survival is relevant to therapeutic applications requiring engraftment and potentially to nonengraftment applications as well. MSCs are a mixture of progenitors at different stages of cellular aging, but the contri
Autor:
Katie C. Russell, Kim C. O'Connor, Julie Glowacki, Sean D. Madsen, H. Alan Tucker, Bruce A. Bunnell
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-14 (2017)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background Mesenchymal stem cells (MSCs) are a mixture of progenitors that are heterogeneous in their regenerative potential. Development of MSC therapies with consistent efficacy is hindered by the absence of an immunophenotype of MSC heterogeneity.
Autor:
Sean D. Madsen, Sean H. Jones, H. Alan Tucker, Margaret K. Giler, Dyllan C. Muller, Carson T. Discher, Katie C. Russell, Georgina L. Dobek, Mimi C. Sammarco, Bruce A. Bunnell, Kim C. O'Connor
Publikováno v:
Biotechnology and Bioengineering. 117
Autor:
Sean D, Madsen, Sean H, Jones, H Alan, Tucker, Margaret K, Giler, Dyllan C, Muller, Carson T, Discher, Katie C, Russell, Georgina L, Dobek, Mimi C, Sammarco, Bruce A, Bunnell, Kim C, O'Connor
Publikováno v:
Biotechnol Bioeng
In vivo mesenchymal stem cell (MSC) survival is relevant to therapeutic applications requiring engraftment and potentially to non-engraftment applications as well. MSCs are a mixture of progenitors at different stages of cellular aging, but the contr
Autor:
H. Alan Tucker, Andrew S. Gaynor, Wendy D. Schober, Kim C. O'Connor, Shuwen Lin, Katie C. Russell, Bruce A. Bunnell, Karen L. Strickler, Michelle Lacey, Michael Andreeff
Publikováno v:
Tissue Engineering Part A. 19:2253-2266
Cellular heterogeneity of mesenchymal stem cells (MSCs) impedes their use in regenerative medicine. The objective of this research is to identify potential biomarkers for the enrichment of progenitors from heterogeneous MSC cultures. To this end, the
Autor:
Katie C. Russell, Bonnie L. Barrilleaux, Michelle Lacey, Kim C. O'Connor, Kristin E. Meyertholen, Donald G. Phinney
Publikováno v:
BMC Proceedings, Vol 5, Iss Suppl 8, p O14 (2011)
BMC Proceedings
BMC Proceedings
Background The regenerative capacity of mesenchymal stem cells (MSCs) is contingent on their content of multipotent progenitors [1]. Despite its importance to the efficacy of MSC therapies, the clonal heterogeneity of MSCs remains poorly defined. To
Autor:
Darwin J. Prockop, Donald G. Phinney, Kim C. O'Connor, Katie C. Russell, Benjamin W. Fischer-Valuck, Bonnie L. Barrilleaux
Publikováno v:
Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009 ISBN: 9789400708839
Human mesenchymal stem cells (MSCs) from bone marrow possess a remarkable capacity to home to and regenerate damaged tissue, but the molecular mechanisms governing their migration and homing are not well defined. The present study reveals that a pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae07ca2081f69b60f0391c728b80fd07
https://doi.org/10.1007/978-94-007-0884-6_26
https://doi.org/10.1007/978-94-007-0884-6_26
Autor:
Kim C. O'Connor, Donald G. Phinney, Katie C. Russell, Jennifer K. Gilliam, H. Alan Tucker, Michelle Lacey
Human mesenchymal stem cells (MSCs) from bone marrow are a heterogeneous ensemble of progenitors and lineage-committed cells, with a broad range of regenerative properties. Ex vivo expansion to produce sufficient quantities of MSCs is essential for m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05729998fb02b2b3e1ad5131205b577e
https://europepmc.org/articles/PMC3178709/
https://europepmc.org/articles/PMC3178709/
Autor:
Katie C. Russell, Kim C. O'Connor, Kristin E. Meyertholen, Michelle Lacey, Donald G. Phinney, Bonnie L. Barrilleaux
Publikováno v:
Stem cells (Dayton, Ohio). 28(4)
In regenerative medicine, bone marrow is a promising source of mesenchymal stem cells (MSCs) for a broad range of cellular therapies. This research addresses a basic prerequisite to realize the therapeutic potential of MSCs by developing a novel high